Director Gline Matthew 🟡 adjusted position in 358.5K shares (1 derivative) of Roivant Sciences Ltd. (ROIV) at $27.70 ($9.9M) Transaction Date: Mar 30, 2026 | Filing ID: 000034
Director Sukhatme Mayukh 🟡 adjusted position in 217.3K shares (1 derivative) of Roivant Sciences Ltd. (ROIV) at $27.70 ($6.0M) Transaction Date: Mar 30, 2026 | Filing ID: 000033